Cortex Pharmaceuticals, Inc. to Present at the 14th Annual BIO Investor Forum
Cortex CEO James S. J. Manuso, Ph.D. to Present Glen Rock, N.J., October 19, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive and central sleep apneas and drug-induced respiratory depression, announces that it will be presenting at the 14th Annual BIO…
Cortex Pharmaceuticals, Inc. to Present at Rodman & Renshaw 17th Annual Global Investment Conference
James S. J. Manuso, Ph.D., New Cortex CEO, to Present GLEN ROCK, NJ — September 8, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive sleep and central apneas and drug-induced respiratory depression, announces that it will be presenting at the Rodman &…
Cortex Pharmaceuticals, Inc. Announces Appointment of James S. J. Manuso, Ph.D., as President and Chief Executive Officer, Vice Chairman of the Board of Directors
Dr. Arnold S. Lippa, Ph.D., to Continue as Executive Chairman of the Board of Directors and Chief Scientific Officer GLEN ROCK, NJ – (Marketwired – Aug 19, 2015) – Cortex Pharmaceuticals, Inc. (OTCQB: CORX) (“Cortex” or the “Company”), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today…